Hafsah Ramjane, T. Bahorun, B. Ramasawmy, D. Ramful-Baboolall, N. Boodia, O. Aruoma, V. Neergheen
{"title":"Exploration of the Potential of Terrestrial and Marine Biodiversity for the Development of Local Nutraceutical Products: A Case for Mauritius","authors":"Hafsah Ramjane, T. Bahorun, B. Ramasawmy, D. Ramful-Baboolall, N. Boodia, O. Aruoma, V. Neergheen","doi":"10.25259/ajbps_3_2021","DOIUrl":null,"url":null,"abstract":"Nutraceuticals and natural health products globally represent one of the fastest growing sectors of research and development leading to novel products intended for disease risk reduction and human health promotion. The global nutraceutical market is expected to grow at a compound annual growth rate of 8.3% from 2020 to 2027 to reach USD 722.5 billion by 2027. There is a need to respond to this sector by exploring the local resources to target the production of innovative products from plant/marine biofactors with high prospects for commercial ventures. This paper explores the nutraceutical potentials enshrined in biodiversity values in a small island state in view to promote sustainable agricultural development to facilitate available resources for the development of regimen for the management of health and disease and in essence, pharmacotherapy. The reported phytochemical composition and pharmacological activities, of the terrestrial flora and marine organisms with high propensity for development and production of nutraceutical products will be discussed. Bioactive phytochemicals encompassing the immensely diverse groups of phenolic acids, flavonoids, terpenoids, alkaloids, possess therapeutic virtues including anti-diabetic, antihypertensive, anticancer, anti-inflammatory, and immunomodulatory attributes, all of which are highly relevant to the budding nutraceutical industry.","PeriodicalId":93408,"journal":{"name":"American journal of biopharmacy and pharmaceutical sciences","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of biopharmacy and pharmaceutical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/ajbps_3_2021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Nutraceuticals and natural health products globally represent one of the fastest growing sectors of research and development leading to novel products intended for disease risk reduction and human health promotion. The global nutraceutical market is expected to grow at a compound annual growth rate of 8.3% from 2020 to 2027 to reach USD 722.5 billion by 2027. There is a need to respond to this sector by exploring the local resources to target the production of innovative products from plant/marine biofactors with high prospects for commercial ventures. This paper explores the nutraceutical potentials enshrined in biodiversity values in a small island state in view to promote sustainable agricultural development to facilitate available resources for the development of regimen for the management of health and disease and in essence, pharmacotherapy. The reported phytochemical composition and pharmacological activities, of the terrestrial flora and marine organisms with high propensity for development and production of nutraceutical products will be discussed. Bioactive phytochemicals encompassing the immensely diverse groups of phenolic acids, flavonoids, terpenoids, alkaloids, possess therapeutic virtues including anti-diabetic, antihypertensive, anticancer, anti-inflammatory, and immunomodulatory attributes, all of which are highly relevant to the budding nutraceutical industry.